Sudhir S Kushwaha M.D.
Cardiologist | Cardiovascular Disease200 1st St SW Rochester MN, 55905
Dr. Sudhir Kushwaha is a cardiologist practicing in Rochester, MN. Dr. Kushwaha specializes in diagnosing, monitoring, and treating diseases or conditions of the heart and blood vessels and the cardiovascular system. These conditions include heart attacks, heart murmurs, coronary heart disease, and hypertension. Dr. Kushwaha also practices preventative medicine, helping patients maintain a heart-healthy life.
Education and Training
Univ London, London Hosp Med Coll (See -) 1981
Internal MedicineAmerican Board of Internal MedicineABIM
Internal MedicineAmerican Board of Internal MedicineABIM- Cardiovascular Disease
- Does ischemic preconditioning limit infarct size in non-Q-wave myocardial infarction?
- Catheter ablation of atrial flutter in a heart transplant recipient.
- Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases.
- Endothelial progenitor cells are decreased in blood of cardiac allograft patients with vasculopathy and endothelial cells of noncardiac origin are enriched in transplant atherosclerosis.
- Changes in myocardial echo amplitude during reversible ischaemia in humans.
- Cauda equina syndrome associated with ankylosing spondylitis in a female.
- Cardiac structure and function.
- Association of angiotensin-converting enzyme inhibitors and serum lipids with plaque regression in cardiac allograft vasculopathy.
- Dipyridamole vasodilator response after human orthotopic heart transplantation: quantification by oxygen-15-labeled water and positron emission tomography.
- Relation between cyclic variation in echo amplitude and segmental contraction in normal and abnormal hearts.
- Pulmonary arterial hypertension: current therapeutic strategies.
- Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.
- 'Rapping' up cardiac allograft vasculopathy.
- Conversion to sirolimus as primary immunosuppression attenuates the progression of allograft vasculopathy after cardiac transplantation.
- Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients.
- Sirolimus as primary immunosuppressant reduces left ventricular mass and improves diastolic function of the cardiac allograft.
- Proliferation signal inhibitors and cardiac allograft vasculopathy.
- Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
- Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients.
- Device therapy and cardiac transplantation for end-stage heart failure.
- De novo development of eosinophilic myocarditis with left ventricular assist device support as bridge to transplant.
- Long-term maintenance therapy for post-cardiac transplant monoclonal lymphoproliferative disorder: caveat mammalian target of rapamycin.
- Pathophysiological changes after cardiac transplantation: the role of chronic inflammation and rejection.
- Changes in renal function after implantation of continuous-flow left ventricular assist devices.
- Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation.
- Valvular regurgitation in heart-lung transplant recipients: a Doppler color flow study.
- Readmissions after implantation of axial flow left ventricular assist device.
- Combined heart and liver transplantation: protection of the cardiac graft from antibody rejection by initial liver implantation.
- Combined heart and liver transplant attenuates cardiac allograft vasculopathy compared with isolated heart transplantation.
- Repeated episodes of thrombosis as a potential mechanism of plaque progression in cardiac allograft vasculopathy.
- Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
- Attenuation of cardiac allograft vasculopathy by sirolimus: Relationship to time interval after heart transplantation.
- Frailty and outcomes after implantation of left ventricular assist device as destination therapy.
- Intraoperative transesophageal echocardiographic guidance of total artificial
- Contemporary strategies in the diagnosis and management of heart failure.
- Ischemic cardiomyopathy is associated with coronary plaque progression and higher event rate in patients after cardiac transplantation.
- mTOR inhibitors as primary immunosuppression after heart transplant: confounding
- Clinical implications of intracoronary imaging in cardiac allograft vasculopathy.
- Evaluation of coronary adventitial vasa vasorum using 3D optical coherence tomography--animal and human studies.
- Attenuation in peripheral endothelial function after continuous flow left ventricular assist device therapy is associated with cardiovascular adverse events.
- Role of ventricular assist therapy for patients with heart failure and restrictive physiology: Improving outcomes for a lethal disease.
- Use of Post-acute Care Services and Readmissions After Left Ventricular Assist
- Suspected ARVC in the Athlete: Do T-Wave Findings Really Help in Diagnosis?
- Proximal thoracic aorta dimensions after continuous-flow left ventricular assist device implantation: Longitudinal changes and relation to aortic valve insufficiency.
- Association between the vasa vasorum and the atherosclerotic changes in cardiac allograft vasculopathy: volumetric analysis.
- The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update.
- Outcomes of Patients Implanted Using a Left Thoracotomy Technique for a Miniaturized Centrifugal Continuous-Flow Pump.
- Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
- Recent Advances in Mammalian Target of Rapamycin Inhibitor Use in Heart and Lung Transplantation.
- Kidney transplantation as a therapeutic option for end-stage renal disease developing after heart transplantation.
- Sex Related Differences in the Risk of Antibody-Mediated Rejection and Subsequent Allograft Vasculopathy Post-Heart Transplantation: A Single-Center Experience.
- Effect of Pretransplant Continuous-Flow Left Ventricular Assist Devices on Cellular and Antibody-Mediated Rejection and Subsequent Allograft Outcomes.
- Early Gains in Renal Function Following Implantation of HeartMate II Left Ventricular Assist Devices May Not Persist to One Year.
- Prediction of right ventricular failure after ventricular assist device implant: systematic review and meta-analysis of observational studies.
- Renal Allograft Outcome After Simultaneous Heart and Kidney Transplantation.
- Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation.
- Leprosy deformities. II. As parameters to monitor the effectivity of leprosy control programme.
- Leprosy deformities. I. An epidemiological study in a rural area of Rajasthan.
- Leprosy in eastern region of Rajasthan.
- Use of CAT scanning in the diagnosis and management of hepatic artery aneurysm.
- Coronary endothelial function in cardiac transplant recipients with accelerated coronary disease.
- Late endothelial function of free and pedicled internal mammary artery grafts.
- Effect of beta blockade on the neurohumoral and cardiopulmonary response to dynamic exercise in cardiac transplant recipients.
- Mirizzi syndrome: its awareness and management.
- Heart Transplant, Heart Failure, Pulmonary Hypertension
- MemberMinnesota Medical Association/Zumbro Valley
- Massachusetts General Hospital
- London Chest Hospital in London, England, in Cardiology and Thoracic Medicine and University of London in London, England, in Medicine
- Research Fellowship - Honorary Lecturer in Cardiology: Harefield Hospital Cardiology
- Research Fellowship - Honorary Lecturer in Cardiology: MRC Cyclotron Unit, Hammersmith Hospital Cardiology
- Fellow : Massachusetts General Hospital, Harvard University Cardiology
Sudhir S Kushwaha M.D.'s Practice location
Rochester, MN 55905Get Direction
Sudhir S Kushwaha M.D.'s reviewsWrite Review
Patient Experience with Dr. Kushwaha
- What is Cardiac Ablation?
Cardiac ablation is a procedure used for atrial fibrillation (a-fib) treatment, which is an irregular beating of the heart. Doctors may recommend the procedure when other methods of treatment such as drugs and heartbeat reset aren’t successful.If atrial fibrillation, or an irregular heart rate,...
- Who Should You Call if You Have a Congestive Heart Failure?
Congestive heart failure does not indicate that your heart has stopped working; instead what it indicates is that your heart is pumping blood at a slower rate than normal. Because the blood moves through the heart and the body at a much slower rate, the pressure in the heart builds up. Hence, the...
- What are The Signs and Symptoms of Atrial Fibrillation?
What are The Signs and Symptoms of Atrial Fibrillation?Atrial fibrillation also called A-Fib is a condition of the heart which causes irregular heartbeats or arrhythmia. It causes abnormal vibrations in the atria chamber of the heart and also the ventricle chamber. In a healthy human heart, the...
- What Is an Arrhythmia?
An arrhythmia is the violations of the frequency, rhythm, and sequence of heart contractions.Why do arrythmias occur?...
- Ehlers-Danlos Syndrome: Symptoms, Causes, Diagnosis, and Treatment
What is Ehlers-Danlos syndrome (EDS)?Ehlers-Danlos syndrome (EDS) is a group of genetic disorders that affect the body’s connective tissues, which are proteins that support the blood vessels, skin, bones, and other organs in the body. Connective tissues also provide elasticity and strength to the...
- Ten Potential “Heartbreakers”
Although heredity and age can contribute to the demise of a healthy heart, there are still some precautions you can take to prevent heart disease. Some precautions include:1. SmokingSmoking has a profound effect on an individual's blood pressure, and it can also cause blood clots. A smoker may also...
- James J Milavetz MD5979 Fashion Blvd Salt Lake City UT 84107
- Thomas W. Rooke M.D.200 1st St SW Rochester MN 55905
- Nedaa Skeik MD920 E 28th St Minneapolis MN 55407
- Krishna M. Pamulapati M.D.200 1st St SW Rochester MN 55905
- Suraj Kapa MD200 1st St SW Rochester MN 55905
- Rajmony Pannu M.D.200 1st St SW Rochester MN 55905